Skip to menu Skip to content Skip to footer

Innovations in peptide-based drug design (2011-2014)

Abstract

The overall aim of this project is to develop innovative generic strategies to facilitate the development of peptides as new drugs. Peptides are naturally occurring sequences of amino acids, and are the most abundant organic molecules in cells, with fundamental roles in defining life, ageing, disease and death in all organisms. They therefore are regarded as important drug leads, but because synthetic peptides have limited stability and bioavailability this promise has so far not been realised. In this project we aim to overcome these major limitations, by developing strategies to stabilise peptides, and then applying the findings to selected targets to demonstrate how peptides can become the next generation of pharmaceuticals.

Experts

Professor David Craik

Affiliate of The Centre for Chemistry and Drug Discovery
Centre for Chemistry and Drug Discovery
Institute for Molecular Bioscience
Affiliate of Centre for Marine Science
Centre for Marine Science
Faculty of Science
Centre Director of ARC COE for Innovations in Peptide and Protein Science
ARC Centre of Excellence for Innovations in Peptide and Protein Science
Institute for Molecular Bioscience
Affiliate Professor of School of Biomedical Sciences
School of Biomedical Sciences
Faculty of Medicine
UQ Laureate Fellow - GL
Institute for Molecular Bioscience
David Craik
David Craik

Professor David Fairlie

Centre Director of The Centre for Chemistry and Drug Discovery
Centre for Chemistry and Drug Discovery
Institute for Molecular Bioscience
Affiliate of ARC COE for Innovations in Peptide and Protein Science
ARC Centre of Excellence for Innovations in Peptide and Protein Science
Institute for Molecular Bioscience
Centre Director of Institute for Molecular Bioscience
Institute for Molecular Bioscience
NHMRC Leadership Fellow and Group Leader
Institute for Molecular Bioscience
David Fairlie
David Fairlie